Focused On-demand Library for Dynein axonemal assembly factor 5

Focused On-demand Libraries - Reaxense Collaboration

Explore the Potential with AI-Driven Innovation

This extensive focused library is tailor-made using the latest virtual screening and parameter assessment technology, operated by the Receptor.AI drug discovery platform. This technique is more effective than traditional methods, offering compounds with improved activity, selectivity, and safety.

Our selection of compounds is from a large virtual library of over 60 billion molecules. The production and distribution of these compounds are managed by our partner Reaxense.

The library includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.

Our high-tech, dedicated method is applied to construct targeted libraries.

Fig. 1. The sreening workflow of Receptor.AI

Our methodology leverages molecular simulations to examine a vast array of proteins, capturing their dynamics in both isolated forms and in complexes with other proteins. Through ensemble virtual screening, we thoroughly account for the protein's conformational mobility, identifying critical binding sites within functional regions and distant allosteric locations. This detailed exploration ensures that we comprehensively assess every possible mechanism of action, with the objective of identifying novel therapeutic targets and lead compounds that span a wide spectrum of biological functions.

Our library stands out due to several important features:

The Receptor.AI platform compiles comprehensive data on the target protein, encompassing previous experiments, literature, known ligands, structural details, and more, leading to a higher chance of selecting the most relevant compounds.
Advanced molecular simulations on the platform help pinpoint potential binding sites, making the compounds in our focused library ideal for finding allosteric inhibitors and targeting cryptic pockets.
Receptor.AI boasts over 50 tailor-made AI models, rigorously tested and proven in various drug discovery projects and research initiatives. They are crafted for efficacy, dependability, and precision, all of which are key in creating our focused libraries.
Beyond creating focused libraries, Receptor.AI offers comprehensive services and complete solutions throughout the preclinical drug discovery phase. Our success-based pricing model minimises risk and maximises the mutual benefits of the project's success.

partner

Reaxense

upacc

Q86Y56

UPID:

DAAF5_HUMAN

Alternative names:

HEAT repeat-containing protein 2

Alternative UPACC:

Q86Y56; Q69YL1; Q96FI9; Q9NX75

Background:

Dynein axonemal assembly factor 5, also known as HEAT repeat-containing protein 2, plays a pivotal role in the assembly of dynein arms essential for motile cilia function. This cytoplasmic protein ensures the delivery of dynein machinery, facilitating cilium motility by attaching to the axoneme's outer doublet A microtubule.

Therapeutic significance:

Given its crucial role in cilia motility, Dynein axonemal assembly factor 5 is directly implicated in Ciliary dyskinesia, primary, 18, a condition marked by motile cilia abnormalities leading to severe respiratory infections and reduced fertility. Understanding the role of this protein could open doors to potential therapeutic strategies for treating ciliary dysfunctions.